Unknown NA INTERVENTIONAL 2-arm NCT01143584

Efficacy of Rapid Escalation of Cabergoline in Comparison to Conventional Dosing in Prolactin Secreting Macroadenomas.

Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh

Updated 6 times since 2017 Last updated: Jun 11, 2010 Started: May 31, 2010 Primary completion: Dec 31, 2011 Completion: Mar 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01143584, this NA trial focuses on Macroprolactinoma and remains ongoing. Sponsored by Post Graduate Institute of Medical Education and Research, Chandigarh, it has been updated 6 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Apr 2024 — Jul 2024 [monthly]

Unknown Status NA
Jan 2021 — Apr 2024 [monthly]

Unknown Status NA
Jun 2018 — Jan 2021 [monthly]

Unknown Status NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Unknown Status NA

First recorded

May 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Post Graduate Institute of Medical Education and Research, Chandigarh

Data source: PIMERIndia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Chandigarh, India